Terms: = Lung cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2
610 results:
1. Case report: Sintilimab combined with anlotinib as neoadjuvant chemotherapy for metastatic bone tumor resection in patients with PSC.
Bao Z; Yu X; Zheng K; Zhai K; Cui H; Xu M
Front Immunol; 2024; 15():1372279. PubMed ID: 38756778
[TBL] [Abstract] [Full Text] [Related]
2. Determinants of mosaic chromosomal alteration fitness.
Pershad Y; Mack T; Poisner H; Jakubek YA; Stilp AM; Mitchell BD; Lewis JP; Boerwinkle E; Loos RJF; Chami N; Wang Z; Barnes K; Pankratz N; Fornage M; Redline S; Psaty BM; Bis JC; Shojaie A; Silverman EK; Cho MH; Yun JH; DeMeo D; Levy D; Johnson AD; Mathias RA; Taub MA; Arnett D; North KE; Raffield LM; Carson AP; Doyle MF; Rich SS; Rotter JI; Guo X; Cox NJ; Roden DM; Franceschini N; Desai P; Reiner AP; Auer PL; Scheet PA; Jaiswal S; Weinstock JS; Bick AG
Nat Commun; 2024 May; 15(1):3800. PubMed ID: 38714703
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
[TBL] [Abstract] [Full Text] [Related]
4. Six versus four or five cycles of first-line etoposide and platinum-based chemotherapy combined with thoracic radiotherapy in patients with limited-stage small-cell lung cancer: A propensity score-matched analysis of a prospective randomized trial.
Yu TT; Hu X; Liufu WJ; Niu SQ; Lian HM; Ma HL; Wang J; Bao Y; Chen M; Peng F
Cancer Med; 2024 Apr; 13(8):e7215. PubMed ID: 38659392
[TBL] [Abstract] [Full Text] [Related]
5. Predictors of radioiodine (RAI)-avidity restoration for NTRK fusion-positive RAI-resistant metastatic thyroid cancers.
Syed AR; Gorana A; Nohr E; Yuan XK; Amin MASc P; Ghaznavi S; Lamb D; McIntyre J; Eszlinger M; Paschke R
Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38642578
[TBL] [Abstract] [Full Text] [Related]
6. Late-stage modification of complex drug: Base-controlled Pd-catalyzed regioselective synthesis and bioactivity of arylated osimertinibs.
Feng R; Zhen YQ; Wu D; Sun L; Xu JB; Li X; Zhang L; Gao F
Sci Adv; 2024 Mar; 10(10):eadl0026. PubMed ID: 38457511
[TBL] [Abstract] [Full Text] [Related]
7. Phenome-wide association study of ovarian cancer identifies common comorbidities and reveals shared genetics with complex diseases and biomarkers.
Mulugeta A; Lumsden AL; Madakkatel I; Stacey D; Lee SH; Mäenpää J; Oehler MK; Hyppönen E
Cancer Med; 2024 Feb; 13(4):e7051. PubMed ID: 38457211
[TBL] [Abstract] [Full Text] [Related]
8. Arenobufagin inhibits lung metastasis of colorectal cancer by targeting c-MYC/Nrf2 axis.
Wang M; Hu S; Yang J; Yuan L; Han L; Liang F; Zhang F; Zhao H; Liu Y; Gao N
Phytomedicine; 2024 May; 127():155391. PubMed ID: 38452690
[TBL] [Abstract] [Full Text] [Related]
9. Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched multicentre retrospective analysis.
Yao Y; Li B; Song R; Yang L; Zou B; Wang L
Radiat Oncol; 2024 Feb; 19(1):25. PubMed ID: 38413988
[TBL] [Abstract] [Full Text] [Related]
10. Establishment of immortalized Egyptian Rousettus bat cell lines.
Bai L; Tani T; Kobayashi T; Nouda R; Kanai Y; Sano Y; Takami K; Tomita H; Sugano E; Ozaki T; Kiyono T; Fukuda T
FEBS Open Bio; 2024 Apr; 14(4):598-612. PubMed ID: 38373743
[TBL] [Abstract] [Full Text] [Related]
11. Genomic characteristics and immune landscape of super multiple primary lung cancer.
Yang Z; Zhou B; Guo W; Peng Y; Tian H; Xu J; Wang S; Chen X; Hu B; Liu C; Wang Z; Li C; Gao S; He J
EBioMedicine; 2024 Mar; 101():105019. PubMed ID: 38364701
[TBL] [Abstract] [Full Text] [Related]
12. Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in EGFR-mutant non-small cell lung cancer patients.
Yin H; Jia W; Yu J; Zhu H
BMC Cancer; 2024 Feb; 24(1):197. PubMed ID: 38347438
[TBL] [Abstract] [Full Text] [Related]
13. A retrospective analysis of optimal timing of thoracic radiotherapy for driver gene-negative metastatic non-small cell lung cancer.
Wang Y; Gao Z; Zhao W; Li H; Meng X; Li J
Thorac Cancer; 2024 Mar; 15(8):642-653. PubMed ID: 38323356
[TBL] [Abstract] [Full Text] [Related]
14. Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy.
Longo V; Della Corte CM; Russo A; Spinnato F; Ambrosio F; Ronga R; Marchese A; Del Giudice T; Sergi C; Casaluce F; Gilli M; Montrone M; Gristina V; Sforza V; Reale ML; Di Liello R; Servetto A; Lipari H; Longhitano C; Vizzini L; Manzo A; Cristofano A; Paolelli L; Nardone A; De Summa S; Perrone A; Bisceglia C; Derosa C; Nardone V; Viscardi G; Galetta D; Vitiello F
Front Immunol; 2023; 14():1289434. PubMed ID: 38304255
[TBL] [Abstract] [Full Text] [Related]
15. Targeting interleukin-17 in radiation-induced toxicity and cancer progression.
Baindara P
Cytokine Growth Factor Rev; 2024 Feb; 75():31-39. PubMed ID: 38242827
[TBL] [Abstract] [Full Text] [Related]
16. Integration of dosimetric parameters, clinical factors, and radiomics to predict symptomatic radiation pneumonitis in lung cancer patients undergoing combined immunotherapy and radiotherapy.
Nie T; Chen Z; Cai J; Ai S; Xue X; Yuan M; Li C; Shi L; Liu Y; Verma V; Bi J; Han G; Yuan Z
Radiother Oncol; 2024 Jan; 190():110047. PubMed ID: 38070685
[TBL] [Abstract] [Full Text] [Related]
17. Semisynthesis of 5-O-ester derivatives of renieramycin T and their cytotoxicity against non-small-cell lung cancer cell lines.
Buaban K; Innets B; Petsri K; Sinsook S; Chanvorachote P; Chansriniyom C; Suwanborirux K; Yokoya M; Saito N; Chamni S
Sci Rep; 2023 Dec; 13(1):21485. PubMed ID: 38057385
[TBL] [Abstract] [Full Text] [Related]
18. Dosimetric predictors of radiation pneumonitis in patients with prior immunotherapy exposure: A multi-institutional analysis.
Bi J; Meng R; Yang D; Li Y; Cai J; Zhang L; Qian J; Xue X; Hu S; Yuan Z; Verma V; Bi N; Han G
Radiother Oncol; 2024 Jan; 190():110040. PubMed ID: 38042497
[TBL] [Abstract] [Full Text] [Related]
19. A Misleading Case of NTRK-Rearranged Papillary Thyroid Carcinoma.
Germani MM; Boccaccio C; Matrone A; Molinaro E; Alì G; Giordano M; Elisei R; Fontanini G; Cremolini C
Oncologist; 2024 Jan; 29(1):84-88. PubMed ID: 38037189
[TBL] [Abstract] [Full Text] [Related]
20. Targeting oncogenic tert promoter variants by allele-specific epigenome editing.
Kouroukli AG; Rajaram N; Bashtrykov P; Kretzmer H; Siebert R; Jeltsch A; Bens S
Clin Epigenetics; 2023 Nov; 15(1):183. PubMed ID: 37993930
[TBL] [Abstract] [Full Text] [Related]
[Next]
